Spark backs Compliance Control with £110,000
Spark Impact has injected ТЃ110,000 into Compliance Control, a software company targeting the biomedical industry.
The capital was drawn from The North West Fund for Biomedical, a sub-fund of The North West Fund, which is financed by the European Regional Development Fund and the European Investment Bank.
The fresh funding will allow Compliance Control to enhance its sales and marketing strategy.
Company
Based in Northwich, Cheshire, and founded in the 1980s, Compliance Control produces software that allows organisations subject to regulatory standards to monitor their compliance. The software uses a dashboard traffic light system to alert users of potential non-compliance areas, while allowing subscribers access to regulations and guidance records across various jurisdictions.
The company sells its product to sectors including pharmaceutical, life sciences and medical devices.
People
Penny Attridge is a senior investment director at Spark Impact and manager of The North West Fund for Biomedical.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








